A reduced pressure treatment system is provided that includes a canister that is fluidly connected to a tissue site and is configured to receive fluid drawn from the tissue site under the influence of a reduced pressure. A reduced pressure source provides the reduced pressure and is fluidly connected to the tissue site by a fluid communication path, which may include a source conduit, the canister, and a target conduit. A sensing device communicates with the source conduit and is configured to sense a pressure in the source conduit. A valve communicates with the source conduit and is configured to vent the reduced pressure. A processing unit communicates with the sensing device and the valve and is configured to open the valve for a selected amount of time, determine a decay of reduced pressure, and determine a fill status of the canister based on the decay of reduced pressure.

Disclosed herein are several embodiments of a negative pressure appliance and methods of using the same in the treatment of wounds. Some embodiments are directed towards wound dressings comprising a liquid and gas permeable transmission layer, an absorbent layer for absorbing wound exudate, the absorbent layer overlying the transmission layer, a gas impermeable cover layer overlying the absorbent layer and comprising a first orifice, wherein the cover layer is moisture vapor permeable. Some embodiments are directed to improved fluidic connectors or suction adapters for connecting to a wound site, for example using softer, kink-free conformable suction adapters.

A negative pressure wound therapy system with exudate level detection through photoelectric total internal reflection, includes: a negative pressure wound therapy device; a fluid collection canister for collecting exudates, where a side wall of the fluid collection canister protrudes outward to form a protrusion, an angle formed by two planes where two opposite sides of the protrusion are located respectively is greater than 97.2 degrees and smaller than 180 degrees; and at least one detecting module, including: a transmitting unit arranged at one side of the protrusion; a receiving unit arranged at the other side of the protrusion; and a detection control unit, adapted to determine, according to a determination of whether the receiving unit receives the electromagnetic wave or ultrasonic wave signal transmitted by the transmitting unit, whether there exit exudates where the detecting unit is located.

The present invention relates to a wound volume measuring method and device, wherein the method comprises the steps of: disposing a foam dressing on a wound site; hermetically sealing the wound site by attaching a film dressing on skin adjacent to the wound site; supplying a negative pressure to the hermetically sealed space formed between the film dressing and the wound site, and thereby discharging fluid into the hermetically sealed space; measuring the flow of the fluid discharged from the hermetically sealed space; and calculating the volume of the wound site on the basis of the measured fluid flow.

Disclosed systems and methods relate to status indication using a canister of negative pressure wound therapy apparatus. A method of providing a visual indication to a user of a negative pressure wound therapy apparatus can include, by a controller of the negative pressure wound therapy apparatus, determining a plurality of conditions associated with provision of negative pressure wound therapy by a negative pressure source of the negative pressure wound therapy apparatus and causing provision of a plurality of visual indications associated with the plurality of conditions to a user and, by at least one light pipe, transmitting light associated with at least one visual indication of the plurality of visual indications through at least a portion of an interior volume of a canister of the negative pressure wound therapy apparatus.

Assemblies, systems, and methods convey fluid from an internal wound site or body cavity by applying negative pressure from a source outside the internal wound site or body cavity through a wound drain assembly that is placed directly inside the internal wound site or body cavity.

A wound therapy device is disclosed. The wound therapy device may include a housing for covering at least a portion of a wound and for sealing to a body surface of a patient. The housing may also include a liquid collector for retaining liquid therein and a vacuum connection for coupling to a vacuum source. The vacuum connection may be in gaseous communication with the liquid collector. The vacuum connection may be separated from the liquid collector by a liquid barrier.

A method and apparatus are disclosed for determining status of a canister of a topical negative pressure (TNP) system. The method includes the steps of monitoring pressure provided by a pump element of the TNP system, determining at least one characteristic associated with the monitored pressure and determining status of at least one parameter associated with a canister of the TNP system responsive to the determined characteristics.

Embodiments of secure wound therapy systems and methods for operating the systems are disclosed. In some embodiments, the apparatus includes a pressure source, a user interface, and a locking mechanism. The locking mechanism can be in one of at least two states, the at least two states including a first state in which the locking mechanism physically prevents user adjustment of one or more operational parameters with the user interface and a second state in which the locking mechanism does not physically prevent user adjustment of the one or more operational parameters with the user interface. The locking mechanism can include an authentication key and a receiver configured to receive an authentication input, which may be compared to the authentication key. Providing a sufficiently matching authentication input can transition the locking mechanism from the first state to the second state, permitting adjustments to the one or more operational parameters.

A therapy system for treating a tissue site with negative-pressure therapy and/or fluid instillation therapy in response to information received from a diagnostic module is described. The therapy system may include a dressing, a negative-pressure source, a container, and a diagnostic module. The dressing be placed on the tissue site, and the negative-pressure source may be fluidly coupled to the dressing. The container may be fluidly coupled to the dressing and to the negative-pressure source to receive fluid from the tissue site. The diagnostic module may be exposed to gas associated with the fluid from the tissue site. The diagnostic module may comprise a sensor configured to detect a condition of the tissue site and to generate an output based on the detected condition. The sensor may be configured to detect a volatile organic compound. The diagnostic module may be positioned on the container.